Published in Medical Letter on the CDC and FDA, November 6th, 2005
MediGene owns the worldwide marketing rights for the drug and is planning submission for marketing authorization in Europe next year.
Polyphenon E Ointment, the active substance in Polyphenon E Ointment, is a concentrate of catechines with a defined composition, extracted from green tea leaves. MediGene is developing this drug for the treatment of various skin tumors. For the indication genital warts, MediGene estimates the sales potential of this drug at more...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.